MASSACHUSETTS GENERAL HOSPITAL
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial
- First Posted Date
- 2006-12-22
- Last Posted Date
- 2017-10-20
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 85
- Registration Number
- NCT00414726
- Locations
- 🇺🇸
Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, ACC-729C, Boston, Massachusetts, United States
Study of TNF-Antagonism in the Metabolic Syndrome (II)
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00413400
- Locations
- 🇺🇸
MGH, Boston, Massachusetts, United States
Metabolic Effects of Switching Kaletra to Boosted Reyataz
- Conditions
- Interventions
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2010-03-09
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT00413153
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2006-12-13
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT00411047
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms
- Conditions
- Interventions
- First Posted Date
- 2006-12-08
- Last Posted Date
- 2009-09-22
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT00409344
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Study of TNF-Antagonism in Metabolic Syndrome
- First Posted Date
- 2006-12-08
- Last Posted Date
- 2008-05-28
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 56
- Registration Number
- NCT00409318
- Locations
- 🇺🇸
MGH, Boston, Massachusetts, United States
Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus
- Conditions
- First Posted Date
- 2006-11-23
- Last Posted Date
- 2006-11-23
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT00403533
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Lifestyle Modification and Metformin Use in the Treatment of HIV
- Conditions
- Interventions
- First Posted Date
- 2006-11-14
- Last Posted Date
- 2012-09-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT00399360
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
- Conditions
- Interventions
- First Posted Date
- 2006-10-26
- Last Posted Date
- 2022-07-11
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 624
- Registration Number
- NCT00392756
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
- Conditions
- Interventions
- First Posted Date
- 2006-10-26
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT00392665
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States